These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6113031)

  • 41. The calcium dependence of spontaneous and evoked quantal release at the frog neuromuscular junction.
    Barton SB; Cohen IS; van der Kloot W
    J Physiol; 1983 Apr; 337():735-51. PubMed ID: 6603514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transmitter mobilization at the frog neuromuscular junction.
    Alkadhi K; Volle RL
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):261-75. PubMed ID: 23083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Statistical parameters of transmitter release at frog neuromuscular junctions treated with guanidine or tetraethylammonium.
    Volle RL; Branisteanu DD
    J Pharmacol Exp Ther; 1976 Jun; 197(3):653-61. PubMed ID: 6788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Properties of the early phases of crotoxin poisoning at frog neuromuscular junctions.
    Rodrigues-Simioni L; Hawgood BJ; Smith IC
    Toxicon; 1990; 28(12):1479-89. PubMed ID: 2089741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distribution of spontaneous release along the frog neuromuscular junction.
    Tremblay JP; Robitaille R; Grenon G
    Neurosci Lett; 1984 Oct; 51(2):247-52. PubMed ID: 6151156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of physiologic alterations on binomial transmitter release at magnesium-depressed neuromuscular junctions.
    Branisteanu DD; Miyamoto MD; Volle RL
    J Physiol; 1976 Jan; 254(1):19-37. PubMed ID: 175150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time course and magnitude of effects of changes in tonicity on acetylcholine release at frog neuromuscular junction.
    Kita H; van der Kloot W
    J Neurophysiol; 1977 Mar; 40(2):212-24. PubMed ID: 300428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequency and amplitude gradients of spontaneous release along the length of the frog neuromuscular junction.
    Robitaille R; Tremblay JP
    Synapse; 1989; 3(4):291-307. PubMed ID: 2568018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Presynaptic effect of Erythrosin B at the frog neuromuscular junction: ion and photon sensitivity.
    Augustine GJ; Levitan H
    J Physiol; 1983 Jan; 334():65-77. PubMed ID: 6306232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calcium-independent increase of transmitter release at frog end-plate by trinitrobenzene sulphonic acid.
    Kijima H; Tanabe N
    J Physiol; 1988 Sep; 403():135-49. PubMed ID: 3150982
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Measurement of quantal secretion induced by ouabain and its correlation with depletion of synaptic vesicles.
    Haimann C; Torri-Tarelli F; Fesce R; Ceccarelli B
    J Cell Biol; 1985 Nov; 101(5 Pt 1):1953-65. PubMed ID: 3932368
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Equivalence of Ca2+ and Sr2+ in transmitter release from K+-depolarised nerve terminals.
    Mellow AM
    Nature; 1979 Nov; 282(5734):84-5. PubMed ID: 41184
    [No Abstract]   [Full Text] [Related]  

  • 53. Nickel and calcium ions modify the characteristics of the acetylcholine receptor-channel complex at the frog neuromuscular junction.
    Magleby KL; Weinstock MM
    J Physiol; 1980 Feb; 299():203-18. PubMed ID: 6247480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of pH changes on the frequency of miniature end-plate potentials at the frog neuromuscular junction.
    Cohen I; Van Der Kloot W
    J Physiol; 1976 Nov; 262(2):401-14. PubMed ID: 11340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. omega-Conotoxin reduces facilitation of transmitter release at the frog neuromuscular junction.
    Zengel JE; Sosa MA; Poage RE
    Brain Res; 1993 May; 611(1):25-30. PubMed ID: 8100174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of the action of 4-aminopyridine during repetitive stimulation at the neuromuscular junction.
    Molgó J; Lemeignan M; Lechat P
    Eur J Pharmacol; 1979 Jan; 53(3):307-11. PubMed ID: 32061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Binomial analysis of quantal transmitter release at glycerol treated frog neuromuscular junctions.
    Miyamoto MD
    J Physiol; 1975 Aug; 250(1):121-42. PubMed ID: 240928
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of lindane upon transmitter release and end-plate responsiveness in the neuromuscular junction of the frog.
    Joy RM; Vogel SM; Narahashi T
    Neuropharmacology; 1987 Aug; 26(8):1223-9. PubMed ID: 2443872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantal release and facilitation at frog neuromuscular junctions at about 0 degrees C.
    Molgó J; Van der Kloot W
    J Neurophysiol; 1991 Apr; 65(4):834-40. PubMed ID: 1675673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The action of verapamil on the rate of spontaneous release of transmitter at the frog neuromuscular junction.
    Publicover SJ; Duncan CJ
    Eur J Pharmacol; 1979 Feb; 54(1-2):119-27. PubMed ID: 33814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.